105329-22-4

Upstream product

• 111-86-4 n-Octylamine 
• 1145-80-8 N-(benzyloxycarbonyl)-L-serine 

Downstream Products

• 196705-74-5 Acetic acid (2R,3R,4S,5R,6R)-3-acetoxy-6-acetoxymethyl-2-((S)-2-benzyloxycarbonylamino-2-octylcarbamoyl-ethoxy)-5-((2S,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-4-yl ester 
• 1360606-13-8 (2S)-(4-octylcarbamoyloxazol-2-yl)pyrrolidine-1-carboxylic acid benzyl ester 
• 1360606-11-6 (2S)-2-{[(1S)-2-hydroxy-1-(octylcarbamoyl)ethyl]carbamoyl}pyrrolidine-1carboxylic acid benzyl ester 
• 222978-98-5 Acetic acid (2R,3R,4S,5R,6R)-3-acetoxy-6-acetoxymethyl-2-[(S)-2-(benzhydrylidene-amino)-2-octylcarbamoyl-ethoxy]-5-((2S,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-4-yl ester 
• 222978-97-4 N'-Octyl-N²-diphenylmethylene-L-serinoamide 

Relevant academic research and scientific papers

COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE

The present invention provides compounds, that areN-alkyl-2-(l-(5-substituted-2-(3- oxo-3-(trifluoromethylsulfonamido)propyl)benzyl)pyrrolidin-2-yl)oxazole-4-carboxamide wherein the 5 substituent is selected from the group consisting of halo and alkyloxy

FATTY ACID AMIDE HYDROLASE INHIHIBITORS FOR TREATING PAIN

Compounds of Formula 1 are described herein. These compounds may be administered to a patient for treatment of suffering from pain or other FAAH mediated conditions.

High performance polymer supports for enzyme-assisted synthesis of glycoconjugates

Efficient and practical methodology for the construction of carbohydrates, including oligosaccharide derivatives and sphingoglycolipids, was established on the basis of a watersoluble polymer supports having unique linkers that can be cleaved by specific